Legal Insights and Perspectives for the Healthcare Industry

We invite you to join us on Thursday, October 17, for an overview discussion about federal rulemaking, including procedural and de facto changes under the current administration. In this A–Z of Federal Rulemaking webinarSusan Harthill, Jonathan Snare, and Timothy Lynch will discuss the impact of participating in federal rulemaking, how to get involved, the roles of the Office of Management and Budget and Office of Information and Regulatory Affairs, and more.

Register for the webinar now >

The Office of Management and Budget’s (OMB’s) policy statement emphasizes the role of the Congressional Review Act in the rulemaking process and incorporates rulemaking actions that were not consistently subject to prepublication review under standing executive orders. Questions remain regarding the prospects for regulatory gridlock and burdensome delays.

A recent OMB memorandum instructs departments and agencies of the executive branch to submit “guidance documents, general statements of policy, and interpretive rules” to the OMB’s Office of Information and Regulatory Affairs (OIRA) for prepublication review. The April 11 memorandum, which also expands OIRA review to agency rules historically submitted through the centralized process designated in Executive Order 12866, is effective May 11, 2019. Regulatory watchers caution that the OMB’s action could increase the volume of rules that require OIRA review and potentially result in regulatory gridlock and rulemaking delays.